Background: Hypochlorous acid (HOCl) demonstrates rapid and broad antimicrobial activity against planktonic and biofilm phenotype bacteria in vitro. Objectives: To identify the protein content present in breast pockets in vivo and calculate the estimated active concentration of HOCl, (PhaseOne, Integrated Healing Technologies, Franklin, TN) following HOCl-protein interactions. Methods: Fluid samples were collected prior to implant insertion in 18 consecutive patients, representing 36 pocket samples, with all cases being bilateral primary breast augmentations. Samples were evaluated by an independent CLIA approved laboratory for albumin and total protein concentration in g/dL. Results were compared to HOCl solution concentration and protein binding potential to determine availability of free HOCl. Results: The mean tissue sample concentration (right and left breast) was 31.6 mg/dL which translates to 0.0001 mmol per 20 cc of interstitial fluid. Mean total protein levels (right and left breast) were 62.3 mg/dL or 0.000187 mmol per 20 cc interstitial fluid. Based upon potential stoichiometric neutralization of HOCl by proteins in either a 1:1 or 3:1 ratio, using 115 cc of HOCl solution (per breast) at a concentration of 250 ppm/mL or 0.025% HOCl or = 0.48 mmol HOCl/dL, there would be 2950 times the amount of active HOCl at a 1:1 reaction ratio, or 983 times more HOCl assuming a 3:1 reaction ratio. Based on the range of identified levels of protein in individual surgical pockets in the study, there is an estimated 242 to 12,500 times more HOCl molecules than protein at a 3:1 molar ratio of binding or reactive protein.
and exists in equilibrium with its anion of molecular chlorine with reactive consumption occurring quickly at a concentration-dependent rate. 2 HOCl causes protein oxidation locally within an area of tissue inflammation and may interact via chlorination or oxidation with: thiol groups, chlorination of amines, protein enzymes, and conversion of bound and free tyrosine to tyrosyl radical. 3 Additionally, HOCl has anti-inflammatory effects by a removal of inciting foreign bacteria and fungi, inactivating neutrophil byproducts and chemo-attractants. Many in vitro studies suggest that HOCl's additional anti-inflammatory benefits are from the inactivation of bacterial endo and exotoxins and other matrix degrading enzymes. [4] [5] [6] Following its production by the PMN in vivo, HOCl and its derivative taurine chloramine decrease the generation of PMN inflammatory mediators such as PGE 2 , TNF-α, IL-1β, IL-2, and IL-6 in tissue macrophages at the site of inflammation. 7 HOCl also regulates metalloproteinases, and releases activated growth factors. HOCl inactivates PMN-released leukotrienes, including sulfidopeptidic-LTC4-sulfoxide and 6-trans-LTB4 and neutralizes IL-6. 8,9
Interaction of HOCl With Macromolecules
Hypochlorous acid has the potential to react with various proteins, carbohydrates, lipids, DNA, and RNA. [10] [11] [12] [13] [14] Specifically, HOCl oxidizes proteins and their associated sulfhydryl groups. With the potential of multiple points of interaction, the available proteins would be inactivated and the overall amount of intact HOCl reduced. 11, 15 Thus, there is a relationship between the molar concentration of HOCl molecules and the total protein content, which determines HOCl reactivity and the amount of active HOCl available.
Therefore, the microbicidal effect of hypochlorous solution is dependent on HOCl concentration and is more effective than disassociated bleach based chlorine compounds such as hypochlorite. 16 For example, undisassociated HOCl has been reported to be a more effective disinfectant than hypochlorite derivatives (OCL -), with pure HOCl in amber glass reported to be 80 to 100 times more germicidal than Dakins' solution. 17 Bacterial and spore wall disruption by stabilized HOCl is related to oxidation of sulfhydryl enzymes, ring chlorination of amino acids, inhibition of protein synthesis, breaks in DNA, and DNA synthesis and enhanced by molecular neutrality supporting passive diffusion. 1, 18 This results in rapid, in-solution inactivation of Gram-positive and Gram-negative species and fungi. Stabilized hypochlorous acid has effective biofilm impairment capabilities and has been shown at 1/32 dilution (6 ppm) to penetrate biofilm while enhancing fibroblast migration. 1 Temperature and storage materials determine the stability, antimicrobial properties, and rate of chlorine decline in prepared solutions. 19 Improper storage may lead to the production of chemical byproducts. However, a proprietary method for stabilizing the HOCl molecule in a potent, relative noncytotoxic form has been developed (PhaseOne, 0.025% Integrated Healing Technologies, Franklin, TN). Packaged in amber glass with proprietary methods for its chemical stability, the HOCl solution has been shown to produce more rapid 4-log reduction of bacterial colony counts than other HOCl-bleach based solutions, polyhexamethylene biguanide, and surfactant based cleansers at noncytotoxic concentrations to fibroblasts. 1, 17, 18 Most recently, PhaseOne was shown to be more effective than triple antibiotic solution, 0.05% Chlorhexidine gluconate, and dilute povidone-iodine in the penetration and eradication of Ralstonia pickettii biofilm from the surface of two different types of textured and one type of smooth breast implants in vitro. 20 However, given the reactivity of the HOCl molecule, what is known about the active or effective concentration of such a solution when used in the breast pocket of patient before implant insertion? What is the usual concentration of plasma free protein present in the breast pocket after hemostasis is achieved? What is the binding capacity of HOCl relative to the protein concentrations and thus the relative remaining effective HOCl concentration for microbial killing?
The purpose of this study was to identify the amount of protein present in breast pockets in vivo and calculate the estimated active concentration of HOCl within the breast pocket following HOCl-protein interactions.
METHODS
This study was performed between January and April 2018. Discarded tissue fluid samples from 18 consecutive female patients undergoing breast surgery at the same outpatient facility were included in the study. The patients' ages ranged from 24 to 46 years old with a mean age of 34.5 years. The two lead authors (M.J.H. and M.K.G.) included serial sequenced bilateral breast cases for a total of 36 pockets. Following pocket creation and establishment of hemostasis using accepted surgical technique 20 mL normal saline irrigant was allowed to dwell in the surgical pocket for 60 seconds and the fluid in the pockets was collected. This was done just prior to implant insertion, using sterile syringes placed in sterile bags and placed in chilled buckets. Samples were discarded serosanguinous fluid stored for the sole purpose of identifying their albumin and total protein concentration in g/dL. Samples were deidentified and complied with the Health Insurance Portability and Accountability Act (HIPPA) regulations. IRB approval was not sought in this study and is not required under Title 45 Code of Federal Regulations, part 46.116(c) of the United States, as these research data were recorded in such a manner that the individuals could not be identified directly and the only link to such individuals would be the consent itself, thus representing the primary risk of harm from a breach of confidentiality. The discarded fluid samples represented no risk to the patient as they were collected during an elective surgical procedure for which consent was sought and were analyzed for protein content only, with no further investigation of the patients nor access to their medical records.
The specimens were sent to an independent CLIA approved and certified laboratory with only specimen numbers for reporting and identification. All cases were bilateral primary breast augmentations.
Surgical technique followed the well-established guidelines set forth by Tebbetts 21 on the importance of appropriate hemostasis prior to implant insertion. All samples were primary augmentations equally divided between both submuscular and subglandular implant placement. Just prior to implant insertion the pockets were inspected to confirm hemostasis and 115 mL of 0.025% HOCl solution (PhaseOne, Integrated Healing Technologies, Franklin, TN) was placed on bilateral sides and allowed to dwell for 60 seconds before removal. This volume ensured that several magnitudes of HOCl would neutralize any free floating and intrinsic proteinaceous material secondary to the surgical dissection. The selection of a 60 second vs 5 minute dwell time is dependent on the surgery type (and potential contamination) and was based on the previously reported in vitro study showing eradication of planktonic at one minute and biofilm phenotype R. pickettii at the first 5 minute biofilm assay. 20 
RESULTS
The surgical pocket fluid from 36 bilateral breast pockets, obtained from 18 female patients, were taken to determine both albumin content and total protein concentrations in grams per deciliter. There were no significant differences between the primary augmentation groups of submuscular or subglandular technique.
At its current formulation, PhaseOne's concentration of 0.025% conveys 250 ppm of HOCl with 0.48 mmol HOCl/dL. Based on the mean values (right and left breast) See Table 1 . of 31.6 mg/dL of albumin, this translates to 0.0001 mmol per 20 cc of interstitial fluid. During surgical procedures, a minimum of 115 cc (230 mL divided to each breast) of PhaseOne is recommended for breast pocket irrigation. If you include all of the measured total protein (R and L) with a mean of 62.3 mg/dL or 0.000187 mmol per 20 cc interstitial fluid and utilize the recommend 115 cc of PhaseOne for irrigation on each breast pocket, then you would still have 2950 times the amount of active HOCl available at a 1:1 reaction ratio, or 983-fold more HOCl assuming a 3:1 reaction ratio. Based on the range of identified levels of protein in individual surgical pockets determined in this study (Table 2) , there is an estimated 242 to 12,500 times more HOCl molecules present during irrigation with PhaseOne than available protein at a 3:1 molar ratio of binding or protein reacting. Thus, there should be more than sufficient available HOCl molecules to remain active for antimicrobial and antibiofilm activity as described in previous in vitro studies 19 when using PhaseOne as part of pocket irrigation.
DISCUSSION

Estimation of Protein Binding and Oxidative Neutralization of HOCl
Two major classes of proteins are found in the blood, albumin, and globulin. Serum albumin makes up about 60% of the total protein found in the blood. Produced by the liver, albumin serves a variety of functions including as a carrier protein for many small molecules and ions, as a source of amino acids for tissue metabolism, and as the principle component involved in maintaining osmotic pressure (preventing fluid from leaking out of blood vessels). The remaining 40% of proteins in the plasma are referred to as globulins. The globulin proteins are a varied group. They include enzymes, antibodies, hormones, carrier proteins, and numerous other types of proteins. These proteins are also found in the interstitial fluids in a similar 60:40 ratio. Serum albumin is normally measured between 3.5 to 5.5 g/dL or 35 to 55 g/L.
The interstitial fluid/plasma concentration ratios for albumin, transferrin, globulins, and total proteins were 0.42, 0.42, 0.32, and 0.37. The albumin/globulin ratio in interstitial fluid was found to be 1.60 of the plasma value. 22 We do not know the precise constitutive content or molecular weight of other proteins besides albumin found in the patient samples. A portion of these proteins along with various amounts of red blood cells escape by: a) tissue disruption with blunt instrument, b) capillary leak, c) transudate or exudate forces into the interstitial surgical breast pocket.
Normal Physiological Assumptions
The content of albumin in an otherwise healthy and noninfected surgical breast pocket is approximately that of interstitial fluid 160 mg/dL or 0.0024 mmol/dL based on a molecular weight of 66,500 g, 23 which by virtue of capillary leak following tissue trauma during surgery would be anticipated to be in the breast pocket following control of hemostasis and prior to irrigation. During surgical procedures, a nominal amount of fluid left in the pocket before implant insertion is 20 mL or less of fluid. This volume represents approximately 0.00048 mmol protein per 20 mL of fluid.
The amount of anticipated total protein suggested from capillary leak after pocket creation is reasonable when considering researchers have reported protein loss in wounds to be similar to the amount from insensible loss, or 12 to 25 g/dL. 24 In contrast, burn injuries can be used as an upper limit extreme example of protein and albumin loss. For example, a study of 11 patients experiencing total body surface area burns between 18% and 68% were assessed for protein loss in wound fluid following second degree burn injury. 25 The researchers report the total protein content in wound fluid to be 0.623 ± 0.248 g/ dL with a peak value of 0.0233 ± 0.0071 g/dL for total protein posttrauma at 32 hours. Average albumin concentration in wound fluid was 0.47 ± 0.471g/dL in the same samples. These wounds have a much greater protein loss potential primarily due to the destruction of the epidermis and dermis with severe inflammation following thermal injury.
Based on these ranges of total protein and albumin dependent on level of tissue trauma and inflammation, the amount of free HOCl available after protein oxidative interaction needs to be sufficient to account for total protein fluctuations of 2 to 3 times the normal interstitial content, which would account for differences in tissue trauma from surgical technique and underlying pathology between patients. Additionally, using the principles of the laws of mass action, liberal irrigation of the space to account for these fluctuations is recommended. Choosing the appropriate antiseptic agent includes selection of a product with bactericidal efficacy, the ability to penetrate and disrupt mature bacterial biofilm, and the relative safety of the product to adverse outcomes or cytotoxicity. Common antiseptics utilized in breast implant surgeries include chlorhexidine gluconate, povidone iodine, and triple antibiotic solution (Cefazolin/Gentamicin/Bacitracin). 26 This study represents an important addition to the literature in regards to pocket irrigation and the potential link between BIA-ALCL and identified Gram-negative bacteria. In combination with the previously published reports of PhaseOne's in vitro efficacy against broad spectrum bacteria, fungi, protozoa, viruses, and R. pickettii biofilm, this study verifies that there is sufficient free HOCL following protein interaction in the surgical pocket for the eradication of planktonic and biofilm phenotype organisms. Additionally, the safety profile of PhaseOne compared to povidone-iodine and especially chlorhexidine gluconate solutions further strengthens these findings to provide surgeons with an alternative pocket irrigation for clean and contaminated cases.
Moreover, this study may serve as a potential model for future investigation of pocket irrigation solutions as it is more clinically relevant than current methods testing disinfection of soiled hard surfaces. For example, a recent Australian study by Hu and colleagues 27 sought to compare PhaseOne and 10% povidone-iodine (Betadine) in an in vitro study using 5% bovine calf serum (BCS) to simulate the presence of "biological soil." The study concluded that PhaseOne was ineffective against planktonic and biofilm S. aureus in the presence of either tryptone soy broth or bovine calf serum during in vitro assay. However, the methods utilized in the assays ensured inactivation of all HOCl before introduction to bacterial inoculum. For example, the study described, "5 μL of BCS was added to 95 μL of neat or diluted test antiseptic before testing. Contact time was for 15 minutes and 24 hours." As described by Fisher and colleagues in a commentary, "The Importance of Clinically Relevant Research When Making Comparisons," 28 the amount of moles of protein available in BCS in comparison to the amount of HOCl utilized, with 3 to 4 albumin binding sites for HOCl per mole of protein, ensured that the neat and subsequent dilutions utilized were sufficiently neutralized before introduction to the bacteria. Thus, the outcomes described are not clinically relevant and the use of methods which attempt to compare hard-surface soil testing to an interaction within a breast pocket following hemostasis is misleading.
Povidone-iodine has demonstrated considerable bactericidal efficacy and potential anti-inflammatory attributes in a variety of studies. 29, 30 However, experts suggest that its use is contraindicated in the following: 20 • Patients with known allergies to iodine.
• Patients with hyperthyroidism/thyroid cancer. • Long-term wound packing or continuous irrigation.
• Pregnant and lactating women.
• Children with large surface area wounds due to risk of systemic toxicity.
Povidone iodine has also been suggested to have reduced antimicrobial activity in the presence of wound exudates or body fluids secondary to interaction with organic material. 20 In a study by Gunjan and colleagues, povidone iodine was compared to multiple antimicrobials commonly used to treat infection in burn wounds. 31 The researchers investigated their effects against two microliters of multidrug-resistant isolates of Gram positive and gram-negative bacteria in a bacterial suspension adjusted to 0.5 McFarland turbidity standard, mixed with Mueller-Hinton agar and incubated for 48 hours at 37°C. Povidone iodine in liquid and ointment form was found to not show any activity against the bacterial pathogens tested. Given the broad spectrum antimicrobial activity of povidone iodine shown in the in vitro literature, the question of its effectiveness in the presence of proteins in the surgical space is warranted given the preference for sustained release iodophors such as cadexomer iodine in the chronic wound to avoid such concerns. The cytotoxicity of povidone iodine is concentration and exposure duration dependent and experimental findings are inconsistent in the literature, relative to clinical interpretation and utility. Both cytotoxic and noncytotoxic effects of povidone iodine on keratinocytes and fibroblasts have been demonstrated in reviews of the in vitro and in vivo literature, however, these differences are likely design dependent with unknown translation to direct clinical relevance. 29 The choice of surgical irrigation therefore may be related to speed of effectiveness against both planktonic and biofilm phenotype bacteria thereby decreasing the total time required to dwell in the surgical pocket to achieve desired outcomes.
Limitations
The primary limitation of this study is the inability to establish an exactly precise protein content of the surgical pocket (vs the reasonable estimate provided from the removed fluid), or evaluation of HOCl-protein binding in real time and is reliant on the samples of surgical pocket fluid by which to create a comparison. In this study, free protein is represented by the fluid samples taken, which may not account for 100% of all potential pocket protein remaining on the pocket wall. However, the authors were not able to identify other specific techniques in the literature where this can be quantified in real time during the surgical procedure. Following an extensive literature search, no distinct methods of quantification of all available protein in a surgical pocket could be identified. Even with this limitation withstanding, the amount of total free HOCl available following pocket irrigation with PhaseOne is sufficient to handle 2 to 3 times the amount of protein described. Based upon comparison with other exudates and wound fluids described in the literature, these ranges suggest there should be enough available HOCl following PhaseOne irrigation for eradication of bacteria or biofilm.
CONCLUSIONS
This study demonstrates the relative protein content present within a surgically created breast pocket following hemostasis in adult surgical patients. Given the level of albumin and total protein content found in breast pocket samples, there are 100's to 1000's times higher levels of available HOCl molecules in PhaseOne solution during pocket irrigation, and there is sufficient available HOCl to maintain antimicrobial effectiveness. In conjunction with previously demonstrated superiority to other commonly used antimicrobial irrigations (povidone iodine, chlorhexidine gluconate, triple antibiotic solution) pure, HOCl stabilized in amber glass may be the preferred pocket irrigation solution based on its safe, rapid, and effective antimicrobial and antibiofilm properties. 32 Current studies to demonstrate the safety of use with a variety of textured and smooth breast implants are currently in progress and will be presented in a subsequent publication. 
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